Monday, June 16, 2025
| 08:00–09:00 | Registration and welcome coffee |
| 09:00–09:10 | Welcome address (Bozena Kaminska - Chair of the Organizing Committee) |
| 09:10-13.40 | Session: Pediatric brain tumor: pathobiology and therapy (chairs: Dolores Hambardzumyan, Bozena Kaminska) |
| 09:10–10:00 | Keynote lecture: Form Follows Function: Cellular and Developmental Architecture of Pediatric Brain Tumors Mariella Filbin, Dana-Farber Cancer Institute, USA |
| 10:00–10:35 | Epigenomic Landscapes of H3K27M Mutant Gliomas Jacek Majewski, McGill University, Canada |
| 10:35–11:10 | Myeloid cell heterogeneity and their functions in pediatric high-grade gliomas Dolores Hambardzumyan, Mount Sinai Icahn School of Medicine, USA |
| 11:10–11:40 | Coffee break |
| 11:40–12.15 | Cell state and plasticity defining drug sensitivity and resistance in diffuse midline glioma Chris Jones, The Institute of Cancer Research, UK |
| 12:15–13.00 | Oral presentations (3x15 min) |
| 13.00-13.45 | Lunch break |
| 13.45-17.00 | Session: Glioma plasticity and microenvironment (chairs: Christel Herold-Mende, Aleksandra Ellert-Miklaszewska) |
| 13.45-14.20 | Dissecting gliomas by single cell and spatial genomics Mario Suva, Massachusetts General Hospital and Harvard Medical School, USA |
| 14.20-14.55 | Ido Amit, Weizmann Institute of Science, Israel |
| 14.55-15.20 | Immune microenvironment of gliomas with different genetic drivers Bozena Kaminska, Nencki Institute, Poland |
| 15.20–15.50 | Coffee break |
| 15.50-16.25 | Christel Herold-Mende, University of Heclasselberg, Germany |
| 16.25-17.00 | Modeling and modulating antitumor immunity in 3D-bioprinted human brain tumoroids Ronit Satchi-Fainaro, Tel Aviv University, Israel |
| 17:00–18.45 | Poster session part I |
| 19:00–21:00 | Welcome reception |
Tuesday, June 17, 2025
| 09:00–12:40 | Session: Brain tumor immunology and immunotherapy (chairs: Dinorah Friedman-Morvinski, Wiesława Grajkowska) |
| 09:00–9:35 | Mapping microglia – tumor crosstalk in pediatric brain cancer Florent Ginhoux, Institute Gustave Roussy, France |
| 09:35–10:10 | Targeting T cells to brain tumors Michel Platten, German Cancer Research Center (DKFZ), Germany |
| 10.10-10:45 | Duane Mitchell, University of Florida, USA |
| 10:45–11.15 | Coffee break |
| 11:15-11.50 | Generating metabolically superior CART cells as a novel immunotherapy to treat brain tumors Dinorah Friedmann-Morvinski, Tel Aviv University, Israel |
| 11.50–12.40 | Keynote lecture: Oncolytic immunoactivation to convert the GBM microenvironment Antonio Chiocca, Harvard Medical School, USA |
| 12.40-13.30 | Lunch break |
| 13.30–18:00 | Session: Brain tumor pathobiology, diagnostics & therapy (Chairs: Bartosz Wojtas, Joanna Trubicka) |
| 13:30-14.05 | Molecular classification of meningiomas Felix Sahm, German Cancer Research Center (DKFZ), Germany |
| 14:05–14:40 | Harnessing metabolic checkpoints for improved immune-targeted therapy against brain metastases Lisa Sevenich, Frankfurt Cancer Institute, Germany |
| 14:40–15:05 | Synthetic super-enhancers enable selective expression of anti- cancer payloads for viral gene therapy Steve Pollard, University of Edinburgh, UK |
| 15:05–15:35 | Coffee break |
| 15:35–16:10 | Varun Venkataramani, University of Heidelberg, Germany |
| 16:10–16:45 | Multiome analysis of local peritumoral glioblastoma cells uncovers phenotypically unique subpopulations Lene Uhrbom, Uppsala University, Sweden |
| 16:45-17.35 | Keynote lecture: Epigenetic reprogramming of the tumor immune microenvironment in mutant IDH1 gliomas Maria Castro, University of Michigan Medical School, USA |
| 17:35–19:30 | Poster session part II |
| 20:00-23:00 | Gala dinner (by invitation) |
Wednesday, June 18, 2025
| 09:00–12:55 | Session: Brain tumor pathobiology, diagnostics & therapy (chairs: Katarzyna Leszczynska, Marta Maleszewska) |
| 09:00–09:30 | Oral presentations (2x15 min) |
| 09:30–10:05 | Advances in neurosurgery Radosław Rola, Medical University of Lublin |
| 10:05–10:40 | Gliomagenesis as the corruption of an injury-regenerative process Peter Dirks, The University of Toronto, Canada |
| 10:40–11:10 | Coffee break |
| 11:10–11:45 | Reprogramming the immune microenvironment in glioblastoma: results from an immune-mediated gene therapy Phase I clinical trial Pedro Lowenstein, University of Michigan Medical School, USA |
| 11:45-12:20 | Targeting glioma immune escape: from mechanisms to novel therapies Patrick Roth, University of Zurich, Switzerland |
| 12:20–12:50 | Oral presentations (2x15 min) |
| 12:50-13:00 | Closing remarks | Best Poster Award ceremony |
| 13.00-14.00 | Lunch break |
| 14.30–16:00 | Warsaw sightseeing guided tour or Run for HIT-GLIO (5 or 10 K run at the Pole Mokotowskie) |